Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Brenda D. Jamerson, PharmD: Effect of Bupropion SR on Specific Symptom Clusters of Depression: Analysis of the 31-Item Hamilton Rating Scale for Depression
1
x
$
30.00
Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial
1
x
$
30.00
Artículo original: Efectos cardiovasculares y recomendaciones en el uso de psicofarmacos
1
x
$
0.00
Efficacy of Omega-3 Fatty Acids in Mood Disorders
1
x
$
30.00
Carol Vidal Castro, MD - Reboxetine: An Alternative for Induced Bruxism
1
x
$
30.00
Psychopharmacology Bulletin VOL 36 Supplement No. 2 - Full Issue Stacked PDF
1
x
$
60.00
Branimir Margetic: A Case of Stuttering During Treatment with Levomepromazine
1
x
$
30.00
Continuous Positive Airways Pressure Treatment in a Patient with Sleep Apnea—Hypopnea Syndrome and Coexisting Bipolar Disorder
1
x
$
30.00
Psychopharmacology Bulletin VOL 37 Supplement No. 1 - Full Issue Stacked PDF
1
x
$
60.00
Takefumi Suzuki, MD, PhD: A Potentially Aborted Neuroleptic Malignant Syndrome Following Seclusion Against Uncontrollable Water Intoxication
1
x
$
30.00
Philip T. Ninan, MD: New Insights Into the Diagnosis and Pharmacologic Management of Generalized Anxiety Disorder
1
x
$
30.00
View Cart
Checkout
Home
Store
“Philip T. Ninan, MD: New Insights Into the Diagnosis and Pharmacologic Management of Generalized Anxiety Disorder” has been added to your cart.
View cart
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Establishing a ‘Gateway’ for Patients with Anxiety
$
0.00
Add to cart
Details
WHEN BIGGER IS BETTER: Necessity as the Mother of Medical Invention
$
0.00
Add to cart
Details
Ethical Issues In Schizophrenia: Considerations for Treatment and Research
$
0.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
0.00
Add to cart
Details
Genetics of Schizophrenia: Recent Advances
$
0.00
Add to cart
Details
Gender and Schizophrenia
$
0.00
Add to cart
Details
Efficacy of Combined Pharmacological and Cognitive- Behavioral Treatments For Anxiety Disorders
$
0.00
Add to cart
Details
Psychiatric Bulletin: Late-Breaking Clinical News
$
0.00
Add to cart
Details
The MentalFitness Interview: David Shaffer, FRCP, FRCPsych, on the Rise and Fall of the Teen Suicide Rate
$
0.00
Add to cart
Details
Cause & Effect: Dealing with the Loss of a Spouse
$
0.00
Add to cart
Details
Anxiety Disorders: Vast Progress but a Long Journey Ahead
$
0.00
Add to cart
Details
Economic Impacts of Anxiety Disorders
$
0.00
Add to cart
Details
Panic Disorder During Pregnancy
$
0.00
Add to cart
Details
Recognition and Treatment of Anxiety Disorders in Primary Care
$
0.00
Add to cart
Details
Anxiety and Other Emotional Factors in Noncardiac Chest Pain
$
0.00
Add to cart
Details
Does Isotretinoin Cause Depression and Suicide? By J. Douglas Bremner, MD
$
0.00
Add to cart
Details
Nota del Director Editorial: En vivo desde Nueva York, les presentamos Psiquiatría y Salud Integral
$
0.00
Add to cart
Details
Dr. Juan E. Mezzich y Dr. Miguel R. Jorge: ¡Bienvenidos a Psiquiatría y Salud Integral!
$
0.00
Add to cart
Details
Psiquiatría y Salud Integral: El consejo editorial de PSI incluye los siguientes psiquiatras y médicos:
$
0.00
Add to cart
Details
Utilización del nombre de los fármacos
$
0.00
Add to cart
Details
1
2
…
44
Next
Page load link
Go to Top
